{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=IPOL", "query": { "intervention": "IPOL" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 19, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=IPOL&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-05T08:34:27.646Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05077137", "title": "A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Melanoma" ], "interventions": [ { "name": "Tetanus Diptheria Vaccine", "type": "BIOLOGICAL" }, { "name": "Polio Boost Immunization", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2021-09-07", "completion_date": "2027-07-01", "has_results": false, "last_update_posted_date": "2026-07-08", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05077137" }, { "nct_id": "NCT00166062", "title": "Safety and Effectiveness of Computer Screening for Intimate Partner Violence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Domestic Violence", "Perpetration" ], "interventions": [ { "name": "Screening patients for IPV", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": null, "start_date": "2004-01", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2013-09-20", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00166062" }, { "nct_id": "NCT05327426", "title": "Intradermal Fractional Dose IPV (fIPV) in Combination With dmLT", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Poliomyelitis" ], "interventions": [ { "name": "Intradermal fractional dose inactivated polio vaccine (fIPV) in combination with recombinant double mutant heat labile toxin, LT(R192G/L211A), (dmLT)", "type": "BIOLOGICAL" }, { "name": "Intradermal fractional dose inactivated polio vaccine (fIPV)", "type": "BIOLOGICAL" }, { "name": "Monovalent oral poliomyelitis vaccine (mOPV), Sabin strain", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Vermont", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 19, "start_date": "2022-04-01", "completion_date": "2024-08-25", "has_results": false, "last_update_posted_date": "2023-11-29", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 1, "location_summary": "Burlington, Vermont", "locations": [ { "city": "Burlington", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT05327426" }, { "nct_id": "NCT00806195", "title": "Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis", "Meningococcal Infection" ], "interventions": [ { "name": "MenACWY-CRM197", "type": "BIOLOGICAL" }, { "name": "DTaP (Diptheria, Tetanus, Pertussis) Vaccine", "type": "BIOLOGICAL" }, { "name": "Hib (Haemophilus influenza b) Vaccine", "type": "BIOLOGICAL" }, { "name": "IPV (Inactivated Polio Vaccine) Vaccine", "type": "BIOLOGICAL" }, { "name": "Pneumococcal conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "MMR (Measles, Mumps, and Rubella) Vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella Vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A Virus", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "55 Days to 89 Days" }, "enrollment_count": 7744, "start_date": "2008-12", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2013-07-09", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 130, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Tuscon, Arizona + 107 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Tuscon", "state": "Arizona" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00806195" }, { "nct_id": "NCT01686503", "title": "Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Polio Immunity" ], "interventions": [ { "name": "IPOL (Sanofi Pasteur) inactivated polio vaccine booster dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eastern Virginia Medical School", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 231, "start_date": "2012-09", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2015-02-05", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 1, "location_summary": "Norfolk, Virginia", "locations": [ { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01686503" }, { "nct_id": "NCT00263692", "title": "Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diphtheria", "Acellular Pertussis", "Tetanus" ], "interventions": [ { "name": "Prophylaxis: Diphtheria, tetanus, pertussis, poliovirus type 1, type 2 and type 3", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "4 Years to 6 Years" }, "enrollment_count": 401, "start_date": "2002-11", "completion_date": "2004-09", "has_results": false, "last_update_posted_date": "2016-09-15", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 15, "location_summary": "Jonesboro, Arkansas • Fountain Valley, California • Oakland, California + 12 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Marietta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00263692" }, { "nct_id": "NCT03207750", "title": "This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rotavirus Infection", "Rotavirus Vaccines" ], "interventions": [ { "name": "Rotarix", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Prevenar 13", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 1280, "start_date": "2017-09-14", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2020-12-29", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 40 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Daly City", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207750" }, { "nct_id": "NCT01000311", "title": "A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Disease" ], "interventions": [ { "name": "MenACWY-CRM", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV/Hib", "type": "BIOLOGICAL" }, { "name": "HBV", "type": "BIOLOGICAL" }, { "name": "PCV", "type": "BIOLOGICAL" }, { "name": "MMR", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "55 Days to 89 Days" }, "enrollment_count": 529, "start_date": "2009-11", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Canoga Park", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000311" }, { "nct_id": "NCT00148941", "title": "Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tetanus", "Acellular Pertussis", "Diphtheria" ], "interventions": [ { "name": "SB213503 lot 1", "type": "BIOLOGICAL" }, { "name": "SB213503 lot 2", "type": "BIOLOGICAL" }, { "name": "SB213503 lot 3", "type": "BIOLOGICAL" }, { "name": "Infanrix", "type": "BIOLOGICAL" }, { "name": "IPOL", "type": "BIOLOGICAL" }, { "name": "M-M-R II", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "4 Years to 6 Years" }, "enrollment_count": 4209, "start_date": "2005-01-06", "completion_date": "2006-12-04", "has_results": true, "last_update_posted_date": "2020-02-05", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 24, "location_summary": "Little Rock, Arkansas • Antioch, California • Daly City, California + 20 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Antioch", "state": "California" }, { "city": "Daly City", "state": "California" }, { "city": "Fairfield", "state": "California" }, { "city": "Fremont", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00148941" }, { "nct_id": "NCT03530124", "title": "Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Apnea", "Apnea Neonatal", "Prematurity" ], "interventions": [ { "name": "PCV13", "type": "BIOLOGICAL" }, { "name": "DTaP", "type": "BIOLOGICAL" }, { "name": "HBV", "type": "BIOLOGICAL" }, { "name": "IPV", "type": "BIOLOGICAL" }, { "name": "Hib", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": null, "sex": "ALL", "summary": "6 Weeks and older" }, "enrollment_count": 223, "start_date": "2018-07-17", "completion_date": "2021-11-01", "has_results": true, "last_update_posted_date": "2024-02-14", "last_synced_at": "2026-09-05T08:34:27.646Z", "location_count": 4, "location_summary": "Atlanta, Georgia • Chapel Hill, North Carolina • Durham, North Carolina + 1 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03530124" } ] }